CIDRAP newsletters options
(CIDRAP News) – A medical team from Tennessee today described the diagnosis and medical care of the first patient sickened in the ongoing fungal meningitis outbreak, the case that triggered an investigation by the state's public health officials and led to the uncovering of the problem.
Oct 19, 2012
(CIDRAP News) – Federal health officials are inviting the public to weigh in on whether research on H5N1 avian influenza viruses, including strains modified in the lab to make them more transmissible, is risky enough to require new safety regulations and precautions.
Oct 18, 2012
(CIDRAP News) – Several developments are having an impact on reducing tuberculosis (TB) infections and deaths in several countries, but the disease's burden is still enormous, and response to multidrug-resistant TB (MDR-TB) remains slow, the World Health Organization (WHO) said yesterday in its latest report on the global TB situation.
(CIDRAP News) – Fourteen more cases and four more deaths were reported today in a multistate fungal meningitis outbreak linked to contaminated steroids provided by a Massachusetts pharmacy, which was raided yesterday by federal agents.
Oct 17, 2012
Oct 16, 2012
(CIDRAP News) – Nineteen more patients have been sickened in a fungal meningitis outbreak linked to contaminated steroid injections, and a federal official today urged clinicians to contact patients who received other drugs made by the company involved, in view of worrisome investigative findings.
The world needs much better influenza vaccines, but the quest for them faces a formidable barrier: overconfidence about the effectiveness of existing influenza vaccines.
Editor’s Note: This article covers research conducted by CIDRAP scientists. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.
Oct 12, 2012
– Federal officials today announced that testing in the multistate meningitis outbreak has found fungus in 50 unopened vials of the steroid linked to the outbreak and that Michigan officials reported the first joint infection in a patient who received the recalled drug.
